News
Public · Published
CONCORDBIO: Q2 consolidated net profit reached Rs. 6,957.20 lakhs; a 1:1 bonus issue is planned
Concord Biotech reported second-quarter consolidated net profit of Rs. 6,957.20 lakhs on revenue of Rs. 30,907.02 lakhs, with first-half net profit at Rs. 12,726.87 lakhs. The board declared a 1:1 bonus issue, setting November 4, 2026 as the record date.
Published:
Updated:
What happened
Concord Biotech reported second-quarter consolidated net profit of Rs. 6,957.20 lakhs on revenue of Rs. 30,907.02 lakhs, with first-half net profit at Rs. 12,726.87 lakhs. The board declared a 1:1 bonus issue, setting November 4, 2026 as the record date.
Confirmed
Global impact / market context
A 1:1 bonus issue gives each shareholder one extra share for every share held, increasing the share count without raising new money. This can make the stock price look lower per share, which may make it easier for smaller investors to buy.
Analyst inference
The profit figures show the company's core earnings for the quarter and half year, giving investors a base to judge future performance. The bonus plan is a separate decision that changes share count, not company cash or underlying profit.
Analyst inference
What to watch
- November 4, 2026 is the record date for the 1:1 bonus issue, so shareholders on record by that date should receive the extra shares. Confirmed
- The board has proposed a 1:1 bonus issue, meaning one new share for each existing share, which still requires the usual steps to complete. Proposed
- Watch whether future profit keeps pace as the share count doubles, because profit per share, which means profit divided by total shares, will fall mechanically after the bonus. Analyst inference
Evidence
- Original source link unavailable